Investors in Ar
Serendipity Partners
VC FirmSerendipity Partners is a strategic, hands-on investor and partner that accelerates growth in Nordic healthcare companies. With deep sector expertise and a focus on sustainable growth.Serendipity Partners is a strategic, hands-on investor and partner that accelerates growth in Nordic healthcare companies. With deep sector expertise and a focus on sustainable growth
Convexa Capital Ventures
VC FirmConvexa is a leading Norwegian-based venture capital company that invests in early-stage and growth technology companies with disruptive technologies. They focus on promising high growth and exceptional returns for their investments.
Datum AS
VC FirmDatum is an investment group based in Oslo, Norway, with a twofold strategy of active ownership and long-term investments. They manage a diverse portfolio including liquid investments in stocks, commodities, and foreign exchange.
Bertel O Steen Kapital
VC FirmBertel O. Steen Kapital invests in unlisted Nordic growth companies with a focus on small and medium-sized enterprises. They take both majority and minority positions, partnering with founders and investors to drive sustainable and profitable growth.
FinStart Nordic
Corporate VCFinstart Nordic, a strategic investment arm of SpareBank 1 SR Bank, invests in Nordic fintech, technology, and impact companies, striving to be valuable partners through building and investing in innovative ventures.
BlueLion Incubator
AcceleratorIncubator for ICT and Clean Tech startups in Zurich, Switzerland. We are the only non-profit incubator in Zurich that focuses on pre-seed startups. Being part of our community gets you free access to our extensive network of experts, mentors, and investors, and personal coaching. Bluelion is a non profit organisation founded in 2012 by the City of Zurich, ETHZ, UZH, Swisscom, ZKB, and Christian Wenger.
BlueHealth Innovation Center
AcceleratorBlueHealth Innovation Center is driving the digital transformation of healthcare for Students. We support HealthTech entrepreneurs from the start. BlueHealth Innovation Center, acquired by imec.istart, stimulates innovation in healthcare through a 12-week support program where HealthTech entrepreneurs are prepared for their first investment.
Blue Sparrows MedTech Funds
AcceleratorWe invest money and experience in early stage medtech companies. The Blue Sparrows MedTech Fund invests money and experience in very early-stage medtech companies. The fund is unique in the fact that besides 2 experienced fund managers, a total of 7 young entrepreneurs in medical technology are part of the fund. The aim is to use their recent experience for the purpose of the investments made in the fund.
Blue Bio Value
AcceleratorBlue Bio Value is an accelerator that scales up marine biobased solutions to global market applications in different industries. Ideas as powerful as the ocean - The world needs your sustainable solutions, now more than ever. Blue Bio Value is an international business acceleration and ideation programme based in Portugal dedicated to the blue bioeconomy, and we want you to be a part of it.
Blockchain.com
AcceleratorBlockchain.com is a developer of a digital assets platform that offers ways to buy, hold, and use cryptocurrency. The worldβs leading crypto finance house serving people, projects, protocols and institutions since 2011. Global management team with over 200 years of combined experience at some of the most reputable financial institutions, technology companies, and startups.
Blenheim Chalcot
AcceleratorBlenheim Chalcot is a leading active venture builder with operations in London, New York, Mumbai and Hong Kong. Blenheim Chalcot is a global venture builder headquartered in the vibrant Scale Space campus in White City, London. With over 26 years of innovation, we've been at the forefront of creating some of the most groundbreaking GenAI-enabled companies.
BiovelocITA
AcceleratorBiovelocITA is the first Italian accelerator dedicated to biotech. It was founded by Silvano Spinelli, Gabriella Camboni and Sofinnova Partners. The market-leading venture capital company specialising in the biosciences which, in 40 years in business, has funded and supported nearly 500 companies.

